Patents by Inventor Katerina Minioti

Katerina Minioti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • STABLE INJECTABLE PHARMACEUTICAL COMPOSITION OF NEUROKININ 1 RECEPTOR ANTAGONIST AND PROCESS FOR PREPARATION THEREOF
    Publication number: 20200237920
    Abstract: The present invention relates to a controlled release sterile injectable formulation in the form of solution, suspension or sol-gel formulation for intramuscular or subcutaneous administration comprising a therapeutically effective amount of a neurokinin 1 receptor antagonist, in particular Aprepitant or Fosaprepitant or pharmaceutical acceptable salt, derivative or metabolite thereof. It also relates to a process for developing such formulations.
    Type: Application
    Filed: April 17, 2020
    Publication date: July 30, 2020
    Applicant: PHARMATHEN S.A.
    Inventors: EVANGELOS KARAVAS, EFTHIMIOS KOUTRIS, DIMITRIOS BIKIARIS, SOTIRIA CHATIDOU, AMALIA DIAKIDOU, PANAGIOTIS BARMPALEXIS, LOUIZA KONSTANTI, KATERINA MINIOTI
  • Preparation of peptide loaded PLGA microspheres with controlled release characteristics
    Patent number: 9943483
    Abstract: A novel process for the preparation of a long acting injectable composition based on biodegradable poly(D,L-lactide-co-glycolide) microspheres comprising peptide active pharmaceutical ingredients.
    Type: Grant
    Filed: March 31, 2014
    Date of Patent: April 17, 2018
    Assignee: PHARMATHEN S.A.
    Inventors: Evangelos Karavas, Efthymios Koutris, Katerina Minioti, Sotiria Chaitidou, Georgia Papanikolaou, Theofanis Mantourlias
  • PREPARATION OF PEPTIDE LOADED PLGA MICROSPHERES WITH CONTROLLED RELEASE CHARACTERISTICS
    Publication number: 20170281547
    Abstract: A novel process for the preparation of a long acting injectable composition based on biodegradable poly(D,L-lactide-co-glycolide) microspheres comprising peptide active pharmaceutical ingredients.
    Type: Application
    Filed: March 31, 2016
    Publication date: October 5, 2017
    Applicant: PHARMATHEN S.A.
    Inventors: EVANGELOS KARAVAS, EFTHYMIOS KOUTRIS, KATERINA MINIOTI, SOTIRIA CHAITIDOU, GEORGIA PAPANIKOLAOU, THEOFANIS MANTOURLIAS
  • STABLE INJECTABLE PHARMACEUTICAL COMPOSITION OF NEUROKININ 1 RECEPTOR ANTAGONIST AND PROCESS FOR PREPARATION THEREOF
    Publication number: 20150165045
    Abstract: The present invention relates to a controlled release sterile injectable formulation in the form of solution, suspension or sol-gel formulation for intramuscular or subcutaneous administration comprising a therapeutically effective amount of a neurokinin 1 receptor antagonist, in particular Aprepitant or Fosaprepitant or pharmaceutical acceptable salt, derivative or metabolite thereof. It also relates to a process for developing such formulations.
    Type: Application
    Filed: July 6, 2012
    Publication date: June 18, 2015
    Applicant: PHARMATHEN S.A.
    Inventors: Evangelos Karavas, Efthimios Koutris, Dimitrios Bikiaris, Sotiria Chatidou, Amalia Diakidou, Panagiotis Barmpalexis, Louiza Konstanti, Katerina Minioti